首页> 中文期刊> 《中国继续医学教育》 >对比放射治疗联合经导管化疗栓塞治疗中晚期宫颈癌的临床可行性

对比放射治疗联合经导管化疗栓塞治疗中晚期宫颈癌的临床可行性

         

摘要

Objective To compare the clinical feasibility of radiotherapy combined transcatheter embolization treatment of locally advanced cervical cancer.Methods From January 2010 to June 2013, 68 treated cases of patients with locally advanced cervical cancer, they were divided into two groups, each group of 34 patients, and named the rehabilitation group and the control group. Control group mainly used the external exposure with pelvic wild three-dimensional conformal radiotherapy, cavity after treatment, and rehabilitation group mainly adopted radiation combined transcatheter embolization chemotherapy. And the two groups of patients treated in the process of data detailed records, to observe the therapeutic effect of two groups. Results After treatment, the rehabilitation group total effective rate was 85.2% (29/34), patients in the control group total effective rate was 55.8% (19/34), there was statistically signiifcant. ConclusionRadiation combined transcatheter embolization chemotherapy has more significant effect than normal pelvic radiotherapy, and it is easy to follow and adverse reaction.%目的:对比放射治疗联合经导管化疗栓塞治疗中晚期宫颈癌的临床可行性。方法选取我院2010年1月~2013年6月收治的68例中晚期宫颈癌患者,将其分成两个小组,每组34例患者,并命名为康复组和对照组。对照组患者主要采用外照射盆腔野三维适形放疗+腔内后装治疗,而康复组主要采用放射治疗联合经导管化疗栓塞治疗的方式。并将两组患者治疗过程中的数据进行详细的记录,以此观察两组患者治疗的疗效。结果放射治疗联合经导管化疗栓塞治疗后,康复组患者的总有效率为85.2%(29/34),对照组患者总有效率为55.8%(19/34),差异有统计学意义。结论放射治疗联合经导管化疗栓塞治疗比普通的盆腔放疗常规的外照射+腔内后装治疗具有更显著的治疗效果,操作简单易行,不良反应轻。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号